Transcription levels of RUNX1, RUNX2, and RUNX3 were all increased in most types of cancers, including breast, esophageal, head and neck, and pancreatic cancer (Figure 1A). This evidence concerns the gene RUNX2 and familial pancreatic carcinoma.